Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: Controlled attenuation parameter for steatosis

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 910-912

  Berzigotti, Annalisa ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Abbreviations; area under receiving operator characteristics curve; AUROC; CAP; chronic liver disease; CLD; Controlled attenuation parameter; liver stiffness; LS; NAFLD; non alcoholic fatty liver disease; ultrasonography; US

Indexed keywords

ECHOGRAPHY; ELASTOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MALE; PROCEDURES;

ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; MALE;

EID: 84898817466     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.017     Document Type: Editorial

References (20)

1. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
2. M.R. Charlton, J.M. Burns, R.A. Pedersen, K.D. Watt, J.K. Heimbach, and R.A. Dierkhising Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
3. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
4. T. Poynard, V. Ratziu, J. McHutchison, M. Manns, Z. Goodman, and S. Zeuzem et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 2003 75 85
5. V. de Meijer, B.T. Kalish, M. Puder, and J.N. Ijzermans Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection Br J Surg 97 2010 1331 1339
6. A.L. Spitzer, O.B. Lao, A.A. Dick, R. Bakthavatsalam, J.B. Halldorson, and M.M. Yeh et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment Liver Transpl 16 2010 874 884
7. M.V. Machado, and H. Cortez-Pinto Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal J Hepatol 58 2013 1007 1019
8. S. Dasarathy, J. Dasarathy, A. Khiyami, R. Joseph, R. Lopez, and A.J. McCullough Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study J Hepatol 51 2009 1061 1067
9. M. Sasso, M. Beaugrand, V. de Ledinghen, C. Douvin, P. Marcellin, and R. Poupon et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes Ultrasound Med Biol 36 2010 1825 1835
10. V. de Ledinghen, J. Vergniol, J. Foucher, W. Merrouche, and B.B. Le Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography Liver Int 32 2012 911 918
11. M. Friedrich-Rust, D. Romen, J. Vermehren, S. Kriener, D. Sadet, and E. Herrmann et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD Eur J Radiol 81 2012 e325 e331
12. K. Masaki, S. Takaki, H. Hyogo, T. Kobayashi, T. Fukuhara, and N. Naeshiro et al. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases Hepatol Res 2013 10.1111/hepr.12094 [Epub ahead of print]
13. R.P. Myers, A. Pollett, R. Kirsch, G. Pomier-Layrargues, M. Beaton, and M. Levstik et al. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography Liver Int 32 2012 902 910
14. M. Sasso, I. Tengher-Barna, M. Ziol, V. Miette, C. Fournier, and L. Sandrin et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C J Viral Hepat 19 2012 244 253
15. Y.E. Chon, K.S. Jung, S.U. Kim, J.Y. Park, Y.N. Park, and D.Y. Kim et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population Liver Int 34 2014 102 109
16. V.D. Ledinghen, J. Vergniol, M. Capdepont, F. Chermak, J.B. Hiriart, and C. Cassinotto et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations J Hepatol 60 2014 1026 1031
17. F. Nascimbeni, R. Pais, S. Bellentani, C.P. Day, V. Ratziu, and P. Loria et al. From NAFLD in clinical practice to answers from guidelines J Hepatol 59 2013 859 871
18. L. Castera, J. Foucher, P.H. Bernard, F. Carvalho, D. Allaix, and W. Merrouche et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
19. S. Carvalhana, J. Leitao, A.C. Alves, M. Bourbon, and H. Cortez-Pinto How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound Liver Int 2013 10.1111/liv.12305 [Epub ahead of print]
20. Y. Yilmaz, R. Ergelen, H. Akin, and N. Imeryuz Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography Eur J Gastroenterol Hepatol 25 2013 1330 1334